The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions

被引:0
作者
Omid Sascha Yousefi
Thomas Wilhelm
Karin Maschke-Neuß
Marcel Kuhny
Christian Martin
Gerhard J Molderings
Felix Kratz
Bernd Hildenbrand
Michael Huber
机构
[1] RWTH Aachen University,Medical Faculty, Institute of Biochemistry and Molecular Immunology
[2] RWTH Aachen University,Medical Faculty, Department of Pharmacology and Toxicology
[3] University Hospital of Bonn,Institute of Human Genetics
[4] Tumor Biology Center,Division of Macromolecular Prodrugs
[5] Tumor Biology Center,Department of Clinical Research
来源
Cell Communication and Signaling | / 11卷
关键词
Mast cell; Benzodiazepines; Lyn; SHIP1; Mastocytosis; Inflammation; Allergy;
D O I
暂无
中图分类号
学科分类号
摘要
Activation of mast cells (MCs) can be achieved by the high-affinity receptor for IgE (FcεRI) as well as by additional receptors such as the lipopolysaccharide (LPS) receptor and the receptor tyrosine kinase Kit (stem cell factor [SCF] receptor). Thus, pharmacological interventions which stabilize MCs in response to different receptors would be preferable in diseases with pathological systemic MC activation such as systemic mastocytosis. 1,4-Benzodiazepines (BDZs) have been reported to suppress MC effector functions. In the present study, our aim was to analyze molecularly the effects of BDZs on MC activation by comparison of the effects of the two BDZs Ro5-4864 and clonazepam, which markedly differ in their affinities for the archetypical BDZ recognition sites, i.e., the GABAA receptor and TSPO (previously termed peripheral-type BDZ receptor). Ro5-4864 is a selective agonist at TSPO, whereas clonazepam is a selective agonist at the GABAA receptor. Ro5-4864 suppressed pro-inflammatory MC effector functions in response to antigen (Ag) (degranulation/cytokine production) and LPS and SCF (cytokine production), whereas clonazepam was inactive. Signaling pathway analyses revealed inhibitory effects of Ro5-4864 on Ag-triggered production of reactive oxygen species, calcium mobilization and activation of different downstream kinases. The initial activation of Src family kinases was attenuated by Ro5-4864 offering a molecular explanation for the observed impacts on various downstream signaling elements. In conclusion, BDZs structurally related to Ro5-4864 might serve as multifunctional MC stabilizers without the sedative effect of GABAA receptor-interacting BDZs.
引用
收藏
相关论文
共 297 条
[1]  
Oreland L(1988)The benzodiazepines: a pharmacological overview Acta Anaesthesiol Scand Suppl 88 13-16
[2]  
Browne TR(1976)Clonazepam. A review of a new anticonvulsant drug Arch Neurol 33 326-332
[3]  
Kanto J(1981)Benzodiazepines as oral premedicants Br J Anaesth 53 1179-1188
[4]  
Murray MJ(1995)Opioids and benzodiazepines Crit Care Clin 11 849-873
[5]  
DeRuyter ML(2011)Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology Pharmacol Rev 63 243-267
[6]  
Harrison BA(2006)Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol Sci 27 402-409
[7]  
Saari TI(1988)Central-type and peripheral-type benzodiazepine receptors Ann Clin Res 20 348-355
[8]  
Uusi-Oukari M(1992)Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier Proc Natl Acad Sci USA 89 3170-3174
[9]  
Ahonen J(1987)Diazepam and desmethyldiazepam differ in their affinities and efficacies at ‘central’ and ‘peripheral’ benzodiazepine receptors J Pharm Pharmacol 39 388-391
[10]  
Olkkola KT(1990)The effects of clozapine on rat mast cells are different from those of benzodiazepines Gen Pharmacol 21 559-561